Moderna’s COVID Vaccine Sheds Negative Comparison On Myocarditis With BLA Approval

 
• By Sue Sutter

Unlike the current EUA fact sheet, Spikevax’s approved labeling does not state that the vaccine may pose an increased risk of myocarditis ‘relative to other authorized or approved mRNA COVID-19 vaccines.’ Approval brings Moderna a priority review voucher, as did Comirnaty’s approval for BLA sponsor BioNTech.

Trash disposal
Moderna was able to dispose of negative comparison safety language on myocarditis in its approved label, although it's still in the vaccine's EUA fact sheet. • Source: Alamy

More from Vaccines

More from Pink Sheet